This subject phenotype table contains subject ID, tumor size, nodal status, hormone receptor status, gemcitabine treatment, capecitabine treatment, bevacizumab treatment, age at randomization, estrogen receptor status, progesterone receptor status, race, histologic tumor grade, side of cancer, completion of neoadjuvant therapies by protocol, best response status, time to last follow-up in years, censoring code for death, time to the first disease-free survival (DFS) event, and censoring code for TOFF (time to the first DFS event).

pht006409
Beskrivning

pht006409

Alias
UMLS CUI [1,1]
C3846158
De-identified Subject ID
Beskrivning

SUBJECT_ID

Datatyp

text

Alias
UMLS CUI [1,1]
C4684638
UMLS CUI [1,2]
C2348585
Clinical Tumor Size
Beskrivning

CTS

Datatyp

text

Alias
UMLS CUI [1,1]
C0475440
UMLS CUI [1,2]
C0205210
Clinical Nodal Status
Beskrivning

CNS

Datatyp

text

Alias
UMLS CUI [1,1]
C0205210
UMLS CUI [1,2]
C0449927
Hormone Receptor Status
Beskrivning

HR

Datatyp

text

Alias
UMLS CUI [1,1]
C0019929
UMLS CUI [1,2]
C0449438
Gemcitabine Treatment
Beskrivning

Gemcitabine

Datatyp

text

Alias
UMLS CUI [1,1]
C0045093
UMLS CUI [1,2]
C0749659
Capecitabine Treatment
Beskrivning

Capecitabine

Datatyp

text

Alias
UMLS CUI [1,1]
C0671970
UMLS CUI [1,2]
C0749659
Bevacizumab Treatment
Beskrivning

Bevacizumab

Datatyp

text

Alias
UMLS CUI [1,1]
C0796392
UMLS CUI [1,2]
C0749659
Age at Randomization
Beskrivning

Age

Datatyp

float

Måttenheter
  • years
Alias
UMLS CUI [1,1]
C0001779
UMLS CUI [1,2]
C0011008
UMLS CUI [1,3]
C0034656
years
Estrogen Receptor Status
Beskrivning

ER

Datatyp

text

Alias
UMLS CUI [1,1]
C2919271
Progesterone Receptor Status
Beskrivning

PgR

Datatyp

text

Måttenheter
  • years
Alias
UMLS CUI [1,1]
C2919590
Race
Beskrivning

Race

Datatyp

text

Alias
UMLS CUI [1,1]
C0034510
Histologic Tumor Grade
Beskrivning

Grade

Datatyp

text

Alias
UMLS CUI [1,1]
C0919553
Side of cancer
Beskrivning

Breast

Datatyp

text

Alias
UMLS CUI [1,1]
C0441987
UMLS CUI [1,2]
C0475445
Completion of neoadjuvant therapies by protocol
Beskrivning

NAT_Complete

Datatyp

text

Alias
UMLS CUI [1,1]
C0805732
UMLS CUI [1,2]
C0600558
UMLS CUI [1,3]
C2348563
Best response status
Beskrivning

Response

Datatyp

text

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C2986560
Time to last follow-up in years
Beskrivning

TLFUP

Datatyp

float

Måttenheter
  • years
Alias
UMLS CUI [1,1]
C1265611
UMLS CUI [1,2]
C0439234
UMLS CUI [1,3]
C0444930
UMLS CUI [1,4]
C0589120
years
Censoring code for death
Beskrivning

DEATH

Datatyp

text

Alias
UMLS CUI [1,1]
C3889990
UMLS CUI [1,2]
C0805701
UMLS CUI [1,3]
C1306577
Time to the first DFS event (including recurrent, second primary and death)
Beskrivning

TOFF

Datatyp

float

Måttenheter
  • years
Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C0877248
UMLS CUI [1,3]
C0751623
UMLS CUI [1,4]
C0549379
UMLS CUI [1,5]
C1306577
years
Censoring code for TOFF
Beskrivning

CDFS

Datatyp

text

Alias
UMLS CUI [1,1]
C3889990
UMLS CUI [1,2]
C0805701
UMLS CUI [1,3]
C3846158

Similar models

This subject phenotype table contains subject ID, tumor size, nodal status, hormone receptor status, gemcitabine treatment, capecitabine treatment, bevacizumab treatment, age at randomization, estrogen receptor status, progesterone receptor status, race, histologic tumor grade, side of cancer, completion of neoadjuvant therapies by protocol, best response status, time to last follow-up in years, censoring code for death, time to the first disease-free survival (DFS) event, and censoring code for TOFF (time to the first DFS event).

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
pht006409
C3846158 (UMLS CUI [1,1])
SUBJECT_ID
Item
De-identified Subject ID
text
C4684638 (UMLS CUI [1,1])
C2348585 (UMLS CUI [1,2])
Item
Clinical Tumor Size
text
C0475440 (UMLS CUI [1,1])
C0205210 (UMLS CUI [1,2])
Code List
Clinical Tumor Size
CL Item
2-4cm (1)
CL Item
>4cm (2)
Item
Clinical Nodal Status
text
C0205210 (UMLS CUI [1,1])
C0449927 (UMLS CUI [1,2])
Code List
Clinical Nodal Status
CL Item
negative (0)
CL Item
positive (1)
CL Item
missing (9)
Item
Hormone Receptor Status
text
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
Code List
Hormone Receptor Status
CL Item
negative (0)
CL Item
positie (1)
CL Item
missing (9)
Item
Gemcitabine Treatment
text
C0045093 (UMLS CUI [1,1])
C0749659 (UMLS CUI [1,2])
Code List
Gemcitabine Treatment
CL Item
NO (0)
CL Item
YES (1)
Item
Capecitabine Treatment
text
C0671970 (UMLS CUI [1,1])
C0749659 (UMLS CUI [1,2])
Code List
Capecitabine Treatment
CL Item
NO (0)
CL Item
YES (1)
Item
Bevacizumab Treatment
text
C0796392 (UMLS CUI [1,1])
C0749659 (UMLS CUI [1,2])
Code List
Bevacizumab Treatment
CL Item
NO (0)
CL Item
YES (1)
Age
Item
Age at Randomization
float
C0001779 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0034656 (UMLS CUI [1,3])
Item
Estrogen Receptor Status
text
C2919271 (UMLS CUI [1,1])
Code List
Estrogen Receptor Status
CL Item
Negative (0)
CL Item
Positive (1)
CL Item
missing (9)
Item
Progesterone Receptor Status
text
C2919590 (UMLS CUI [1,1])
Code List
Progesterone Receptor Status
CL Item
Negative (0)
CL Item
Positive (1)
CL Item
missing (9)
Item
Race
text
C0034510 (UMLS CUI [1,1])
Code List
Race
CL Item
white (1)
CL Item
African American (2)
CL Item
Hawaiian/pacific (3)
CL Item
Asian (4)
CL Item
multi-racial (5)
CL Item
unknown (9)
Item
Histologic Tumor Grade
text
C0919553 (UMLS CUI [1,1])
Code List
Histologic Tumor Grade
CL Item
Well (1)
CL Item
Moderate (2)
CL Item
Poor (3)
CL Item
Unknown (9)
Item
Side of cancer
text
C0441987 (UMLS CUI [1,1])
C0475445 (UMLS CUI [1,2])
Code List
Side of cancer
CL Item
Left (1)
CL Item
Right (2)
CL Item
Unknown (9)
Item
Completion of neoadjuvant therapies by protocol
text
C0805732 (UMLS CUI [1,1])
C0600558 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
Code List
Completion of neoadjuvant therapies by protocol
CL Item
No (0)
CL Item
Yes (1)
Item
Best response status
text
C0027651 (UMLS CUI [1,1])
C2986560 (UMLS CUI [1,2])
Code List
Best response status
CL Item
pCR Breast and Nodes (1)
CL Item
pCR Breast (2)
CL Item
Clinical complete response (3)
CL Item
Clinical partial response (4)
CL Item
Clinical stable disease (5)
CL Item
Disease Progression, new lesions etc. (6)
CL Item
Unknown (9)
TLFUP
Item
Time to last follow-up in years
float
C1265611 (UMLS CUI [1,1])
C0439234 (UMLS CUI [1,2])
C0444930 (UMLS CUI [1,3])
C0589120 (UMLS CUI [1,4])
Item
Censoring code for death
text
C3889990 (UMLS CUI [1,1])
C0805701 (UMLS CUI [1,2])
C1306577 (UMLS CUI [1,3])
Code List
Censoring code for death
CL Item
alive at last follow-up (0)
CL Item
dead at last follow-up (1)
CL Item
no follow-up (9)
TOFF
Item
Time to the first DFS event (including recurrent, second primary and death)
float
C0040223 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
C0751623 (UMLS CUI [1,3])
C0549379 (UMLS CUI [1,4])
C1306577 (UMLS CUI [1,5])
Item
Censoring code for TOFF
text
C3889990 (UMLS CUI [1,1])
C0805701 (UMLS CUI [1,2])
C3846158 (UMLS CUI [1,3])
Code List
Censoring code for TOFF
CL Item
event-free at last clinical assessment (0)
CL Item
DFS event (1)
CL Item
no clinical assessment for cancer recurrence (9)